[[LIVER TOXICITY DUE TO RIFAMPICIN MONOTHERAPY IN LATENT TUBERCULOSIS INFECTION].]
; 91(5): 509-513, 2016 May.
Artigo em Japonês | MEDLINE | ID: mdl-28661592
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Rifabutin for treating pulmonary tuberculosis.
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.
Safety and Side Effects of Rifampin versus Isoniazid in Children.
[Clinical experience using rifabutin for treating infection with Mycobacterium tuberculosis in elderly Japanese patients].
Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection.
[PULMONARY TUBERCULOSIS AND TUBERCULOUS PLEURISY COMPLICATED WITH RIFAMPICIN-INDUCED HYPOTHYROIDISM: A CASE REPORT].
Clinical and pharmacological hallmarks of rifapentine's use in diabetes patients with active and latent tuberculosis: do we know enough?
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.
Three months of weekly rifapentine plus isoniazid for latent tuberculosis treatment in solid organ transplant candidates.